Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome

Malcom Randall VA Medical Center

Status: Enrolling

Conditions: Post Intensive Care Syndrome (PICS)

Treatments: Behavioral: Post-ICU Telehealth Follow-up

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT06983496

IRB202401793

Details and patient eligibility

About

The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness.

The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery

Participants will randomized to receive the study intervention or standard of care.

Enrollment: 24 estimated patients

Sex: All

Ages: 18 to 89 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults 18-89 years of age
• Required admission to either medical or surgical ICU
• Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
• Anticipated discharge to home after hospitalization
• Consent from patients themselves or a legally authorized representative if necessary

Exclusion criteria

• Pregnancy
• Incarceration/Imprisonment
• Life expectancy less than 6 months or enrolled in hospice/palliative care
• Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
• Unable to participate in telehealth

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

24 participants in 2 patient groups

Telehealth Intervention Group

Experimental group

Description:

This group will receive the study intervention (i.e. telehealth follow-up appointments at approximately one and three months post-hospital discharge).

Treatment:

Behavioral: Post-ICU Telehealth Follow-up

Standard of Care Group

No Intervention group

Description:

This group will receive standard post-ICU care following hospital discharge.